Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy

Background: Current treatment guidelines for arrhythmogenic right ventricular cardiomyopathy (ARVC) mainly emphasize on prevention of ventricular arrhythmic events. Despite the progressive nature of ARVC, therapeutic options focusing on decelerating disease progression are scarce.Methods and Results...

Full description

Saved in:
Bibliographic Details
Main Authors: Bin Tu, Lingmin Wu, Lihui Zheng, Shangyu Liu, Lishui Sheng, Limin Liu, Zhenghui Zhu, Yan Yao
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
angiotensin-converting enzyme inhibitors
arrhythmogenic right ventricular cardiomyopathy
anti-arrhythmic drug
ventricular arrhythmia
disease progression
Diseases of the circulatory (Cardiovascular) system
RC666-701
Online Access:https://doaj.org/article/83e4375c2c1444a3a25151da276ac3f6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/83e4375c2c1444a3a25151da276ac3f6

Similar Items